La maladie de Parkinson en France (serveur d'exploration) - Corpus (Istex)

Index « Auteurs » - entrée « O. Rascol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
O. R. Hommes < O. Rascol < O. Reyes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000036 (1990) U. Sabatini ; O. Rascol ; P. Celsis ; J. P. Marc-Vergnes ; J. L. MontastrucEffects of apomorphine on cerebral blood flow and extrapyramidal symptoms in Parkinson's disease
000292 (2000) Jj Ferreira ; M. Galitzky ; Jl Montastruc ; O. RascolSleep attacks and Parkinson's disease treatment
000353 (2008) J. C. Sharma ; I. N. Ross ; O. Rascol ; D. BrooksRelationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight
000730 (2013) A. H. V. Schapira ; P. Barone ; R. A. Hauser ; Y. Mizuno ; O. Rascol ; M. Busse ; C. Debieuvre ; M. Fraessdorf ; W. PoewePatient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease
000855 (2013) A. H. V. Schapira ; P. Barone ; R. A. Hauser ; Y. Mizuno ; O. Rascol ; M. Busse ; C. Debieuvre ; M. Fraessdorf ; W. PoeweSuccess rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease
000A27 (2012) S. Perez-Lloret ; L. Nègre-Pagès ; A. Ojero-Senard ; P. Damier ; A. Destée ; F. Tison ; M. Merello ; O. RascolOro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort
000B36 (2013) J. J. Ferreira ; R. Katzenschlager ; B. R. Bloem ; U. Bonuccelli ; D. Burn ; G. Deuschl ; E. Dietrichs ; G. Fabbrini ; A. Friedman ; P. Kanovsky ; V. Kostic ; A. Nieuwboer ; P. Odin ; W. Poewe ; O. Rascol ; C. Sampaio ; M. Schüpbach ; E. Tolosa ; C. Trenkwalder ; A. Schapira ; A. Berardelli ; W. H. OertelSummary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease
000D14 (1989) J L Montastruc ; O. Rascol ; A. RascolA randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
000F29 (1991) A. Agniel ; P. Celsis ; G. Viallard ; J L Montastruc ; O. Rascol ; J F Demonet ; J P Marc-Vergnes ; A. RascolCognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.
001167 (2007) A. Gerdelat-Mas ; M. Simonetta-Moreau ; C. Thalamas ; F. Ory-Magne ; T. Slaoui ; O. Rascol ; C. Brefel-CourbonLevodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
001175 (1994) Jl Montastruc ; Me Llau ; O. Rascol ; Jm SenardDrug‐induced parkinsonism: a review
001247 (2009) A. H. Schapira ; Y. Agid ; P. Barone ; P. Jenner ; M. R. Lemke ; W. Poewe ; O. Rascol ; H. Reichmann ; E. TolosaPerspectives on recent advances in the understanding and treatment of Parkinson’s disease
001276 (2006) J. J. Ferreira ; K. Desboeuf ; M. Galitzky ; C. Thalamas ; C. Brefel-Courbon ; N. Fabre ; J. Senard ; J. Montastruc ; C. Sampaio ; O. RascolSleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers
001305 (2006) M. Horstink ; E. Tolosa ; U. Bonuccelli ; G. Deuschl ; A. Friedman ; P. Kanovsky ; J. P. Larsen ; A. Lees ; W. Oertel ; W. Poewe ; O. Rascol ; C. SampaioReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
001568 (2006) M. Horstink ; E. Tolosa ; U. Bonuccelli ; G. Deuschl ; A. Friedman ; P. Kanovsky ; J. P. Larsen ; A. Lees ; W. Oertel ; W. Poewe ; O. Rascol ; C. SampaioReview of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
001576 (2011) O. RascolDrugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release
001854 (1994) O. Blin ; C. Desnuelle ; O. Rascol ; M. Borg ; H. Peyro Saint Paul ; J. P. Azulay ; F. Billé ; D. Figarella ; F. Coulom ; J. F. Pellissier ; J. L. Montastruc ; M. Chatel ; G. SerratriceMitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy
002124 (1994) O. Rascol ; U. Sabatini ; F. Chollet ; N. Fabre ; J M Senard ; J L Montastruc ; P. Celsis ; J P Marc-Vergnes ; A. RascolNormal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
002227 (1994) J L Montastruc ; O. Rascol ; J M Senard ; A. RascolA randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
002244 (1989) O. Rascol ; M. Clanet ; J. L. Montastruc ; M. Simonetta ; M. J. Soulier-Esteve ; B. Doyon ; A. RascolABNORMAL OCULAR MOVEMENTS IN PARKINSON'S DISEASE
002392 (2010) Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne-Louise Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar-Shira ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak ; Anne-Marie Ouvrard-Hernandez ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche ; Ccile Cazeneuve ; A. Nazli Basak ; Nobutaka Hattori ; Alexandra Drr ; Meriem Tazir ; Avi Orr-Urtreger ; Lluis Quintana-Murci ; Alexis Brice ; Y. Agid ; A.-M. Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; Ph. Damier ; A. Deste ; A. Drr ; F. Durif ; E. Lohmann ; M. Martinez ; C. Penet ; P. Pollak ; O. Rascol ; F. Tison ; C. Tranchant ; A. Troiano ; M. Vrin ; F. Viallet ; M. VidailhetParkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "O. Rascol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i  \
                -Sk "O. Rascol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    O. Rascol
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024